Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Overweight 1Obesity 1Neoplasms 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

pembrolizumab 28Paclitaxel 24Carboplatin 19Bevacizumab 14Specimen Handling 13Magnetic Resonance Spectroscopy 10Doxorubicin 8Cisplatin 8Biopsy 8olaparib 7lenvatinib 7Taxes 7Letrozole 7Megestrol Acetate 6Fulvestrant 6durvalumab 5dostarlimab 5Nivolumab 5Medroxyprogesterone Acetate 5Gemcitabine 5trastuzumab deruxtecan 4abemaciclib 4X-Rays 4Trastuzumab 4Tirzepatide 4Progestins 4Oxaliplatin 4Immunoglobulin G 4Fluorouracil 4Docetaxel 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Estrogen Replacement Therapy × 90 days × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡